This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Translational Genomics Research Institute. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Aditi Bapat: Innovator in Cancer Treatment
Introduction
Aditi Bapat is a prominent inventor based in Phoenix, AZ, who has made significant contributions to the field of cancer treatment. With a focus on innovative methods, she has developed a patent that addresses critical challenges in treating cancers of the endocrine system. Her work exemplifies the intersection of research and practical application in the medical field.
Latest Patents
Aditi Bapat holds a patent for "Methods for the treatment of cancer." This invention is directed towards methods for treating cancer in a subject, particularly cancers of the endocrine system. The method includes administering one or more of a polo-like kinase 1 inhibitor, a mouse double minute 2 inhibitor, and/or a mitotic catastrophe inducing compound. Additionally, the method involves measuring the expression levels of markers such as caspase 8 and caspase 9 to assess the functionality of the caspase cascade in the subject. This patent highlights her innovative approach to cancer therapy.
Career Highlights
Aditi Bapat is affiliated with the Translational Genomics Research Institute, where she collaborates with other researchers to advance cancer treatment methodologies. Her work is characterized by a commitment to improving patient outcomes through scientific innovation.
Collaborations
Some of her notable coworkers include Kimberly Bussey and Michael J Demeure, who contribute to the collaborative environment that fosters groundbreaking research in cancer treatment.
Conclusion
Aditi Bapat's contributions to cancer treatment through her innovative patent demonstrate her dedication to advancing medical science. Her work not only reflects her expertise but also the potential for significant improvements in patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
